← Leaderboards
Jerod S Denton
Vanderbilt University
$12,278,378
Attributed
$15,553,777
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,553,777 · 16
By mechanism
R01$11,266,670 · 7
R33$2,090,737 · 1
R21$1,092,148 · 4
R61$836,039 · 1
T32$170,779 · 1
F32$88,904 · 1
Top collaborators
- Celia M Santi5 shared
- Elaine Shelton4 shared
- Corey R. Hopkins3 shared
- Peter M Piermarini2 shared
- Xinmin Simon Xie1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- C David Weaver$15,228,291
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayPatch ClampElectrophysiology (Science)In VivoHigh Throughput ScreeningPotassium ChannelPharmaceutical ChemistryPotassiumPropertySmall MoleculePhysiologyLeadBiologyStructureLibrariesMolecularPharmaceutical PreparationsIn VitroSeriesAnalogPharmacologyPhysiologicalInhibitor/AntagonistCells
Grant awards (40)
Development of Kv3.1 potentiators for correcting fast-spiking-interneuron hypofunction in schizophrenia and autism spectrum disorder$596,371
R01 · FY2025 · MH · contact PI
Discovery and characterization of selective GIRK1/2 activators and their evaluation in preclinical models of pain$546,237
R01 · FY2025 · NS
Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras$493,978
R01 · FY2025 · DK · contact PI
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance$477,937
R01 · FY2025 · DK · contact PI
Development of Kv3.1 potentiators for correcting fast-spiking-interneuron hypofunction in schizophrenia and autism spectrum disorder$677,025
R01 · FY2024 · MH · contact PI
Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras$474,220
R01 · FY2024 · DK · contact PI
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance$458,819
R01 · FY2024 · DK · contact PI
Development of Kv3.1 potentiators for correcting fast-spiking-interneuron hypofunction in schizophrenia and autism spectrum disorder$695,775
R01 · FY2023 · MH · contact PI
Developing modulators of the sperm-specific potassium channel SLO3 for contraception$658,168
R33 · FY2023 · HD
Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone$528,084
R01 · FY2023 · HD · contact PI
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance$496,687
R01 · FY2023 · DK · contact PI
Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras$493,978
R01 · FY2023 · DK · contact PI
Developing modulators of the sperm-specific potassium channel SLO3 for contraception$630,457
R33 · FY2022 · HD
Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone$528,767
R01 · FY2022 · HD · contact PI
Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras$493,978
R01 · FY2022 · DK · contact PI
Developing modulators of the sperm-specific potassium channel SLO3 for contraception$802,112
R33 · FY2021 · HD
Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone$562,249
R01 · FY2021 · HD · contact PI
Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras$512,228
R01 · FY2021 · DK · contact PI
Development of Distal Nephron Diuretics Targeting Kir4.1/5.1 Heteromeric Potassium Channels$374,853
R01 · FY2021 · DK · contact PI
Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone$679,091
R01 · FY2020 · HD · contact PI
Development of Distal Nephron Diuretics Targeting Kir4.1/5.1 Heteromeric Potassium Channels$413,826
R01 · FY2020 · DK · contact PI
Developing modulators of the sperm-specific potassium channel SLO3 for contraception$397,878
R61 · FY2020 · HD
Training Program in Ion Channel and Transporter Biology$170,779
T32 · FY2020 · NS · contact PI
Developing modulators of the sperm-specific potassium channel SLO3 for contraception$438,161
R61 · FY2019 · HD
Development of Distal Nephron Diuretics Targeting Kir4.1/5.1 Heteromeric Potassium Channels$429,242
R01 · FY2019 · DK · contact PI
Development of small molecule mosquitocides for controlling the primary vector of Zika virus, Aedes aegypti$192,317
R21 · FY2018 · AI
Development of small molecule mosquitocides for controlling the primary vector of Zika virus, Aedes aegypti$255,820
R21 · FY2017 · AI
Molecular pharmacology and physiology of kidney potassium transport$257,115
R01 · FY2014 · DK · contact PI
Molecular pharmacology and physiology of kidney potassium transport$248,097
R01 · FY2013 · DK · contact PI
Molecular pharmacology and physiology of kidney potassium transport$260,533
R01 · FY2012 · DK · contact PI
Chemical probes of the astroglial potassium channel Kir4.1$25,000
R21 · FY2012 · NS · contact PI
Integrative Membrane Physiology in the Post-Genome Era$8,500
R13 · FY2012 · GM · contact PI
Molecular pharmacology and physiology of kidney potassium transport$261,846
R01 · FY2011 · DK · contact PI
Molecular pharmacology and physiology of kidney potassium transport$305,734
R01 · FY2010 · DK · contact PI
Regulation of macrophage activation state by intracellular triglyceride$193,750
R21 · FY2010 · AI · contact PI
Chemical probes of the astroglial potassium channel Kir4.1$155,167
R21 · FY2010 · NS · contact PI
Regulation of macrophage activation state by intracellular triglyceride$193,594
R21 · FY2009 · AI · contact PI
Identification of novel modulators of ROMK K+ channel activity$76,500
R21 · FY2006 · NS · contact PI
Regulation of a CIC channel by an Ste20-like kinase$47,296
F32 · FY2004 · GM
Regulation of a CIC channel by an Ste20-like kinase$41,608
F32 · FY2003 · GM